Brainstorm Financial Statements From 2010 to 2024

BCLI Stock  USD 0.54  0.01  1.89%   
Brainstorm Cell financial statements provide useful quarterly and yearly information to potential Brainstorm Cell Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Brainstorm Cell financial statements helps investors assess Brainstorm Cell's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Brainstorm Cell's valuation are summarized below:
Market Capitalization
36.4 M
Earnings Share
(0.40)
We have found one hundred twenty available fundamental signals for Brainstorm Cell Therapeutics, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Brainstorm Cell Therapeutics prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 11.2 M. Enterprise Value is estimated to decrease to about 11.1 M

Brainstorm Cell Total Revenue

(366,000)

Check Brainstorm Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brainstorm main balance sheet or income statement drivers, such as Depreciation And Amortization of 315 K, Interest Expense of 515 K or Selling General Administrative of 10.6 M, as well as many exotic indicators such as Price To Sales Ratio of 85.28, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Brainstorm financial statements analysis is a perfect complement when working with Brainstorm Cell Valuation or Volatility modules.
  
This module can also supplement Brainstorm Cell's financial leverage analysis and stock options assessment as well as various Brainstorm Cell Technical models . Check out the analysis of Brainstorm Cell Correlation against competitors.

Brainstorm Cell Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total AssetsM4.2 M11.8 M
Slightly volatile
Short and Long Term Debt Total1.9 M1.3 M2.7 M
Slightly volatile
Other Current Liabilities2.4 M2.2 M950.6 K
Slightly volatile
Total Current Liabilities4.2 M7.8 M5.2 M
Slightly volatile
Cash1.2 M1.3 M5.1 M
Pretty Stable
Non Current Assets Total1.6 M2.3 M2.1 M
Slightly volatile
Cash And Short Term Investments1.2 M1.3 M8.6 M
Pretty Stable
Common Stock Total Equity14.5 K13.8 K10.2 K
Slightly volatile
Common Stock Shares Outstanding45.2 M43.1 M22.2 M
Slightly volatile
Liabilities And Stockholders EquityM4.2 M11.8 M
Slightly volatile
Non Current Liabilities Total1.7 M1.3 M1.9 M
Slightly volatile
Other Current Assets308.3 K548 K414.5 K
Slightly volatile
Other Stockholder Equity220.6 M210.1 M112.7 M
Slightly volatile
Total Liabilities5.3 M9.1 M6.2 M
Slightly volatile
Total Current Assets1.8 M1.9 M9.7 M
Pretty Stable
Short Term Debt888.8 K603 K1.2 M
Pretty Stable
Common Stock7.5 K13 K9.6 K
Slightly volatile
Property Plant And Equipment Net1.6 M2.1 M1.9 M
Slightly volatile
Property Plant And Equipment Gross6.4 M6.1 M2.7 M
Slightly volatile
Current Deferred Revenue3.2 MM2.5 M
Slightly volatile
Accounts PayableMM3.7 M
Slightly volatile
Non Currrent Assets Other20.9 K22 K144.4 K
Very volatile
Net Receivables48.5 K51 K649.5 K
Pretty Stable
Other Liabilities266.9 K141.4 K173.7 K
Pretty Stable
Other Assets25.1 K26.4 K157.9 K
Very volatile
Property Plant Equipment6.4 M6.1 M2.5 M
Slightly volatile
Capital Surpluse233 M221.9 M116.7 M
Slightly volatile
Long Term Investments17.1 K18 K34.1 K
Slightly volatile
Non Current Liabilities Other4.4 M4.2 M1.8 M
Slightly volatile
Capital Stock12.8 K13.8 K11.5 K
Slightly volatile
Capital Lease Obligations5.2 M4.7 M3.3 M
Slightly volatile

Brainstorm Cell Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative10.6 M10.1 M5.4 M
Slightly volatile
Other Operating Expenses22.5 M21.4 M13.4 M
Slightly volatile
Total Operating Expenses22.2 M21.2 M13.3 M
Slightly volatile
Research Development7.1 M10.5 M8.7 M
Slightly volatile
Selling And Marketing Expenses1.1 M1.2 M1.3 M
Slightly volatile
Interest Income658.1 K626.8 K186.5 K
Slightly volatile
Reconciled Depreciation218.7 K269 K147 K
Slightly volatile

Brainstorm Cell Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow733.4 K772 KM
Slightly volatile
Depreciation261.6 K265 K156.1 K
Slightly volatile
End Period Cash Flow1.2 M1.3 M5.1 M
Pretty Stable
Stock Based Compensation1.2 M1.9 M1.1 M
Slightly volatile
Change To Netincome1.4 M1.9 M1.3 M
Slightly volatile
Issuance Of Capital Stock13.7 M15.9 M7.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio85.2889.77112
Slightly volatile
Average Payables566.9 K865.2 K895 K
Very volatile
EV To Sales85.4289.92112
Slightly volatile
Payables Turnover0.03220.05350.0298
Slightly volatile
Sales General And Administrative To Revenue0.810.510.5088
Very volatile
Cash Per Share0.02870.03020.4001
Very volatile
Capex To Operating Cash Flow8.0E-49.0E-40.0434
Slightly volatile
Days Payables Outstanding10.5 K6.8 K12.9 K
Slightly volatile
Income Quality1.251.190.8224
Slightly volatile
Intangibles To Total Assets0.00.00.028
Slightly volatile
Current Ratio0.230.24353.0434
Slightly volatile
Graham Number0.961.00632.0419
Pretty Stable
Revenue Per Share0.0280.05540.0554
Very volatile
Debt To Assets0.690.44630.3568
Slightly volatile
Days Of Payables Outstanding10.5 K6.8 K12.9 K
Slightly volatile
Ebt Per Ebit1.140.80191.041
Slightly volatile
Quick Ratio0.160.17322.9609
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.2 K1.1 K241
Slightly volatile
Net Income Per E B T0.780.880.9598
Pretty Stable
Cash Ratio0.160.16671.2111
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.171.00091.0546
Pretty Stable
Fixed Asset Turnover1.892.122.309
Slightly volatile
Capital Expenditure Coverage Ratio1.2 K1.1 K241
Slightly volatile
Debt Ratio0.690.44630.3568
Slightly volatile
Price Sales Ratio85.2889.77112
Slightly volatile
Asset Turnover0.871.641.6492
Very volatile
Gross Profit Margin0.210.160.149
Very volatile

Brainstorm Cell Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap11.2 M11.8 M51.9 M
Pretty Stable
Enterprise Value11.1 M11.7 M49.4 M
Pretty Stable

Brainstorm Fundamental Market Drivers

Cash And Short Term Investments1.3 M

Brainstorm Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Brainstorm Cell Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Brainstorm Cell income statement, its balance sheet, and the statement of cash flows. Brainstorm Cell investors use historical funamental indicators, such as Brainstorm Cell's revenue or net income, to determine how well the company is positioned to perform in the future. Although Brainstorm Cell investors may use each financial statement separately, they are all related. The changes in Brainstorm Cell's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Brainstorm Cell's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Brainstorm Cell Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Brainstorm Cell. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred RevenueM3.2 M
Total Revenue 0.00  0.00 
Cost Of Revenue265 K278.2 K
Stock Based Compensation To Revenue 0.00  0.00 
Sales General And Administrative To Revenue 0.51  0.81 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue 0.00  0.00 
Revenue Per Share 0.06  0.03 
Ebit Per Revenue(0.51)(0.53)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brainstorm Cell in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brainstorm Cell's short interest history, or implied volatility extrapolated from Brainstorm Cell options trading.

Pair Trading with Brainstorm Cell

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainstorm Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will appreciate offsetting losses from the drop in the long position's value.

Moving together with Brainstorm Stock

  0.61MRK Merck Company Earnings Call This WeekPairCorr

Moving against Brainstorm Stock

  0.71ANAB AnaptysBio Financial Report 9th of May 2024 PairCorr
  0.67GNTA Genenta Science SpA Report 24th of April 2024 PairCorr
  0.62JNJ Johnson Johnson Aggressive PushPairCorr
  0.61PCRX Pacira Pharmaceuticals Financial Report 1st of May 2024 PairCorr
  0.58ALKS Alkermes Plc Financial Report 24th of April 2024 PairCorr
The ability to find closely correlated positions to Brainstorm Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainstorm Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainstorm Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainstorm Cell Therapeutics to buy it.
The correlation of Brainstorm Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainstorm Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainstorm Cell Ther moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainstorm Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out the analysis of Brainstorm Cell Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Brainstorm Cell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.40)
Return On Assets
(2.12)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.